A comprehensive clinical study of integrins in acute lymphoblastic leukemia indicates a role of α6/CD49f in persistent minimal residual disease and α5 in the colonization of cerebrospinal fluid
- 28 February 2020
- journal article
- letter
- Published by Taylor & Francis Ltd in Leukemia & Lymphoma
- Vol. 61 (7), 1714-1718
- https://doi.org/10.1080/10428194.2020.1731500
Abstract
(2020). A comprehensive clinical study of integrins in acute lymphoblastic leukemia indicates a role of α6/CD49f in persistent minimal residual disease and α5 in the colonization of cerebrospinal fluid. Leukemia & Lymphoma. Ahead of Print.This publication has 15 references indexed in Scilit:
- Disrupting the leukemia niche in the central nervous system attenuates leukemia chemoresistanceHaematologica, 2020
- Leukaemia hijacks a neural mechanism to invade the central nervous systemNature, 2018
- Integrins in T Cell PhysiologyInternational Journal of Molecular Sciences, 2018
- The ability to cross the blood–cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blastsBlood, 2016
- Role of Integrin Alpha4 in Drug Resistance of LeukemiaFrontiers in Oncology, 2014
- Risk group assignment differs for children and adults 1–45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL‐2008 protocolEuropean Journal of Haematology, 2013
- Integrin signalling and function in immune cellsImmunology, 2012
- High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapseHaematologica, 2011
- Cellular elements of the subarachnoid space promote ALL survival during chemotherapyLeukemia Research, 2011
- The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug ResistanceClinical Cancer Research, 2008